Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes

OBJECTIVE: The study aims to investigate the effect of metformin on Hepatocellular carcinoma (HCC) patients with type 2 diabetes mellitus (T2DM) who received transarterial chemoembolization (TACE) for the first time. METHODS: From January 2016 to December 2019, T2DM patients diagnosed with HCC in Sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Miao-Ling, Wu, Chun-Xue, Zhang, Jian-Bo, Zhang, Hao, Sun, Yuan-Dong, Tian, Shi-Lin, Han, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520252/
https://www.ncbi.nlm.nih.gov/pubmed/36187118
http://dx.doi.org/10.3389/fendo.2022.996228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520252/
https://www.ncbi.nlm.nih.gov/pubmed/36187118
http://dx.doi.org/10.3389/fendo.2022.996228

Ejemplares similares